242 filings
Page 4 of 13
8-K
ear76zjk8myd2
15 Apr 21
Merger of Napo EU and Dragon SPAC targeted for mid-2021
9:04am
8-K
j3gb01
8 Apr 21
Entry into a Material Definitive Agreement
5:21pm
8-K
jhv36
31 Mar 21
Jaguar Health Reports 2020 Financial Results and Business Updates
4:15pm
8-K
zyuvz3 epa7
11 Mar 21
Entry into a Material Definitive Agreement
4:15pm
8-K
kli7p4bbq n8kr
22 Jan 21
Entry into a Material Definitive Agreement
5:01pm
8-K
n4pt3
14 Jan 21
Jaguar Health Announces $15 Million Registered Direct Offering Priced Above-the-Market Under Nasdaq Rules
8:00am
8-K
oeuhf0 e0rc5k
11 Jan 21
Regulation FD Disclosure
8:30am
8-K
k3b0zfa
8 Jan 21
Unregistered Sales of Equity Securities
5:01pm
8-K
g1qnw3 4tg
29 Dec 20
Jaguar Health Reports Voting Results from Special Meeting of Stockholders & Announces December 23rd Investor Webinar
5:03pm
8-K
nuxt72crb6e k7woze
18 Dec 20
Unregistered Sales of Equity Securities
5:00pm
8-K
j3bbhvy27xocrahwwv
10 Dec 20
The Sixth Tranche Accounts Receivable has a gross value of $3,810,587.04, representing customer billings over a 51-day period
8:30am
8-K
m3zolx0pjaq4 9lkc
4 Dec 20
Via Electronic Mail
8:30am
8-K
kqk52rcjf
30 Nov 20
Regulation FD Disclosure
8:30am
8-K
il4lcrgelvq73b sjs
25 Nov 20
Other Events
8:00am
8-K
7cvygddqnbpn4d
20 Nov 20
Unregistered Sales of Equity Securities
5:00pm
8-K
wz4msqdeo7 1y4
16 Nov 20
Jaguar Health, Inc. Reports 2020 Third Quarter Financial Results
8:00am
8-K
gft71zpujx1x792
10 Nov 20
Regulation FD Disclosure
4:15pm
8-K
tzc26
29 Oct 20
Jaguar Health Receives Positive Nasdaq Listing Determination
8:30am
8-K
6s3bni4ia5fgs1
13 Oct 20
Jaguar Health Provides Updates Regarding Company Capitalization Strategy
8:30am
8-K
490oqjcpp6g0s35l
9 Oct 20
Entry into a Material Definitive Agreement
4:40pm